Updated just now · Live
Johnson & Johnson researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company operates through its Innovative Medicine and MedTech segments following the spinoff of its consumer health division.
Johnson & Johnson operates in the Healthcare sector and is a constituent of the S&P 500 index. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for JNJ.
How to read insider trading filings
UnitedHealth Group Incorporated
AbbVie Inc.
Merck & Co., Inc.
Eli Lilly and Company
Thermo Fisher Scientific Inc.
Abbott Laboratories
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). JNJ Stock Intelligence Report. [stoxpulse.com/stocks/jnj]
Disclaimer: The information on this page about Johnson & Johnson (JNJ) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Johnson & Johnson.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
No earnings data available.
This Pharma Stock Is Up 460% Over the Past Year. W...
1h ago
3 Dividend Aristocrats That Look Cheap and Just Hi...
2h ago
StoxPulse AI results for JNJ: Pulse Score 57/100. Primary sentiment trends from 15 news sources and 20 SEC filings indicate a bullish outlook.
Market Cap
$555.64B
P/E Ratio
18.8
EPS
$2.10
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Johnson & Johnson researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company operates through its Innovative Medicine and MedTech segments following the spinoff of its consumer health division.
This Pharma Stock Is Up 460% Over the Past Year. What Could Be Key to Future Gains.
3 Dividend Aristocrats That Look Cheap and Just Hiked Payouts
Mindtickle launches ElevateOS™ -- the first agentic operating system for revenue enablement
Advertising leaders join Rocketium to scale AI-powered creative production platform
Johnson & Johnson Showcases CARTO-Powered Innovation, Including Debut of CARTOSOUND SONATA, to Advance Arrhythmia Care at HRS 2026
[Latest] Global Surgical Drill Bits Market Size/Share Worth USD 540 Million by 2035 at a 5.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Guggenheim Raises Johnson & Johnson (JNJ) Target on Icotyde Upside, Keeps Buy Rating
Johnson & Johnson (JNJ) – One of the 12 High Dividend Stocks Picked by Billionaire Ray Dalio